The new BIOCOM CARD combines various BIOCOM products and services that complement each other perfectly.
Der zweitägige Zukunftsworkshop des Fraunhofer Zentrums für internationales Management und Wissensökonomie lockte Ende Januar viele Besucher ins Dresdener Hygienemuseum.
For the fourth time now, the “Guide to German Medtech Companies” will be published this year.
Just in time for the new year, the updated version of the BIOCOM App is out. Now it is easier to find what you are looking for: A full text search is now available.
Thanks to two major financings for Qiagen and Biontech, 2018 will go down in history as a record year: German biotechnology companies were able to raise more than EUR1.3bn (+95%) from investors for their business development last year. In 2017, the figure was only EUR673m.
BIOCOM is part of the new EU project BE-Rural, which aims to tap the potential of bio-based economies in rural areas.
Marijuana is the most widely trafficked illegal drug worldwide. But the list of European countries that see the clear medical benefits of the plant and want to legalise cannabis for medical purposes has grown long. Is this the beginning of a gold rush in the industry? The cover story of the recently published winter edition of European Biotechnology focuses on this issue.
Only three months to go until the twelfth Berlin Conference on Life Sciences will once again be the venue for all things antimicrobials. The ranks of speakers are filling up. Researchers have until 9th January to submit abstracts for their poster presentations.